NCT05592028

Brief Summary

X-linked dystonia-parkinsonism (XDP) is a rare, X-linked, adult-onset, and progressive movement disorder seen almost exclusively in men from Panay Island in the Philippines. The disease is associated with mutations involving the DYT3/TAF1 gene, and all the cases described so far have been linked to Filipino ancestry. Although XDP is very rare globally, the prevalence is 5.74 per 100,000 individuals in Panay Island and 0.31 per 100,000 in the Philippines as a whole. Majority of patients (95%) were males, and the mean age of onset was 39 years. The mean duration of illness was 16 years, and the mean age of death was 55.6 years.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 24, 2022

Completed
Last Updated

October 24, 2022

Status Verified

August 1, 2022

First QC Date

August 21, 2022

Last Update Submit

August 21, 2022

Conditions

Keywords

High intensity focused ultrasoundpallidothalamic tractotomytranscranial MR-guided focused ultrasound

Interventions

XDP patients will receive unilateral or bilateral transcranial magnetic resonance-guided focused ultrasound pallidothalamic tractotomy.

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old and above
  • have been diagnosed with XDP and confirmed by genetic testing
  • have a skull density ratio (SDR) of \>/= 0.35 on CT scan
  • have psychiatric and medical clearance
  • have passed the neurocognitive test
  • have undergone MRgFUS pallidothalamic tractomy, either unilateral or bilateral,

You may not qualify if:

  • patients aged less than 18 years old
  • patients who have movement disorders other than XDP
  • patients with abnormal neuroimaging findings that would preclude MRgFUS lesioning
  • Skull SDR \< 0.35
  • patients with medical contraindications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Philippine General Hospital

Manila, 1000, Philippines

AVAILABLE

Related Publications (1)

  • Jamora RDG, Khu KJO, Sy MCC, Pascual JSG, Legaspi GD, Aguilar JA. Transcranial magnetic resonance-guided focused ultrasound pallidothalamic tractotomy for patients with X-linked dystonia-parkinsonism: a study protocol. BMC Neurol. 2023 Aug 18;23(1):306. doi: 10.1186/s12883-023-03344-x.

MeSH Terms

Conditions

Dystonia 3, Torsion, X-Linked

Study Officials

  • Roland Dominic G Jamora, MD, PhD

    Department of Neurosciences, University of the Philippines Manila

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Roland Dominic G Jamora, MD, PhD

CONTACT

Kathleen Joy O Khu, MD

CONTACT

Study Design

Study Type
expanded access
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 21, 2022

First Posted

October 24, 2022

Last Updated

October 24, 2022

Record last verified: 2022-08

Locations